Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 1
1988 1
1989 5
1990 1
1991 5
1992 5
1993 7
1994 5
1995 4
1996 10
1997 9
1998 7
1999 9
2000 14
2001 10
2002 21
2003 5
2004 9
2005 14
2006 15
2007 14
2008 18
2009 11
2010 5
2011 13
2012 12
2013 11
2014 9
2015 17
2016 12
2017 9
2018 13
2019 11
2020 7
2021 10
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer.
Kim SE, Kim WJ, Choi D, Lee DY. Kim SE, et al. Breast Cancer Res Treat. 2023 Apr;198(2):231-237. doi: 10.1007/s10549-023-06877-4. Epub 2023 Feb 13. Breast Cancer Res Treat. 2023. PMID: 36781519
RESULTS: The mean age and the pretreatment serum AMH level were 33.2 years and 4.4 ng/mL in goserelin group and 34.2 years and 4.0 ng/mL in leuprorelin group. ...Serum AMH levels decreased significantly in both the goserelin (from 4.4 to 1.2 ng/mL) and leu …
RESULTS: The mean age and the pretreatment serum AMH level were 33.2 years and 4.4 ng/mL in goserelin group and 34.2 years and 4.0 ng …
Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide.
Shim M, Bang WJ, Oh CY, Lee YS, Cho JS. Shim M, et al. Investig Clin Urol. 2019 Jul;60(4):244-250. doi: 10.4111/icu.2019.60.4.244. Epub 2019 May 21. Investig Clin Urol. 2019. PMID: 31294133 Free PMC article.
Changes in testosterone concentration during 9 months of ADT with goserelin 11.34 mg, triptorelin 11.25 mg, and leuprolide 11.25 mg were analyzed using a mixed model. ...The lowest mean testosterone levels during 9 months of treatment were achieved in patients treat …
Changes in testosterone concentration during 9 months of ADT with goserelin 11.34 mg, triptorelin 11.25 mg, and leuprolide 11. …
Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial.
Zong X, Yu Y, Yang H, Chen W, Ding X, Liu S, Li X, Chen X, Jiang C, Xia X, Huang R, Zhu M, Hu J, Liang C. Zong X, et al. JAMA Oncol. 2022 Feb 1;8(2):252-258. doi: 10.1001/jamaoncol.2021.6214. JAMA Oncol. 2022. PMID: 34967844 Free PMC article. Clinical Trial.
INTERVENTIONS: Eligible patients were randomly assigned (1:1) to receive chemotherapy with (n = 165) or without (n = 165) GnRHa. In patients randomized to receive GnRHa, 3.6 mg of goserelin or 3.75 mg of leuprorelin was injected subcutaneously once every 28 days fro …
INTERVENTIONS: Eligible patients were randomly assigned (1:1) to receive chemotherapy with (n = 165) or without (n = 165) GnRHa. In patients …
Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety.
Raja T, Sud R, Addla S, Sarkar KK, Sridhar PS, Talreja V, Jain M, Patil K. Raja T, et al. Indian J Cancer. 2022 Mar;59(Supplement):S142-S159. doi: 10.4103/ijc.IJC_65_21. Indian J Cancer. 2022. PMID: 35343198 Free article. Review.
However, goserelin has shown better efficacy in maintaining T levels 50 ng/dL compared with leuprolide. The incidences of T escape are lower with goserelin and leuprolide than buserelin. Goserelin also has maximum benefit in prostate-specific an …
However, goserelin has shown better efficacy in maintaining T levels 50 ng/dL compared with leuprolide. The incidences of T es …
Editorial comment.
Schellhammer PF. Schellhammer PF. J Urol. 2011 Mar;185(3):854; author reply 854. doi: 10.1016/j.juro.2010.10.091. Epub 2011 Jan 15. J Urol. 2011. PMID: 21239016 No abstract available.
Degarelix.
Frampton JE, Lyseng-Williamson KA. Frampton JE, et al. Drugs. 2009 Oct 1;69(14):1967-76. doi: 10.2165/10484080-000000000-00000. Drugs. 2009. PMID: 19747011
Degarelix is a gonadotropin-releasing hormone (GnRH) receptor antagonist that, in common with GnRH receptor agonists (e.g. leuprolide, goserelin and triptorelin), is indicated for use as an androgen-deprivation therapy in patients with advanced prostate cancer. ...D …
Degarelix is a gonadotropin-releasing hormone (GnRH) receptor antagonist that, in common with GnRH receptor agonists (e.g. leuprolide …
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
De Laurentiis M, Borstnar S, Campone M, Warner E, Bofill JS, Jacot W, Dent S, Martin M, Ring A, Cottu P, Lu J, Ciruelos E, Azim HA, Chatterjee S, Zhou K, Wu J, Menon-Singh L, Zamagni C. De Laurentiis M, et al. Breast Cancer Res Treat. 2021 Oct;189(3):689-699. doi: 10.1007/s10549-021-06334-0. Epub 2021 Aug 19. Breast Cancer Res Treat. 2021. PMID: 34414532 Free PMC article. Clinical Trial.
METHODS: Patients treated with 1 line of prior chemotherapy and no prior endocrine therapy for ABC received ribociclib 600 mg/day (3-weeks-on/1-week-off) plus letrozole 2.5 mg/day and additionally monthly goserelin/leuprolide in men and pre-/perimenopausal women. El …
METHODS: Patients treated with 1 line of prior chemotherapy and no prior endocrine therapy for ABC received ribociclib 600 mg/day (3-weeks-o …
An overview of treatments for endometriosis.
Brown J, Farquhar C. Brown J, et al. JAMA. 2015 Jan 20;313(3):296-7. doi: 10.1001/jama.2014.17119. JAMA. 2015. PMID: 25603001 Review.
BOTTOM LINE: The levonorgestrel-releasing intrauterine system (LNG-IUD), gonadotropin-releasing hormone analogues (GnRHa; nafarelin, leuprolide, buserelin, goserelin, triptorelin), laparoscopic ablation, and excision are associated with relief of pain due to endomet …
BOTTOM LINE: The levonorgestrel-releasing intrauterine system (LNG-IUD), gonadotropin-releasing hormone analogues (GnRHa; nafarelin, leup …
Gonadotropin Releasing Hormone (GnRH) Analogues.
[No authors listed] [No authors listed] 2018 Mar 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Mar 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643199 Free Books & Documents. Review.
Some of these agents are also used to treat benign conditions responsive to hormonal inhibition such as endometriosis, uterine fibroids, precocious puberty and infertility. Leuprolide, goserelin, triptorelin and histrelin are considered GnRH agonists, whereas degare …
Some of these agents are also used to treat benign conditions responsive to hormonal inhibition such as endometriosis, uterine fibroids, pre …
324 results

Searches related to "goserelin leuprorelin"